Why the study?
Does higher small solute clearance (rKt/V ≥0.25 and tKt/V ≥1.75) reduce all-cause mortality in adult patients on continuous ambulatory peritoneal dialysis?
Does higher small solute clearance (rKt/V ≥0.25 and tKt/V ≥1.75) reduce all-cause mortality in adult patients on continuous ambulatory peritoneal dialysis?
In patients on continuous ambulatory peritoneal dialysis, achieving a minimum tKt/V of 1.75 and rKt/V of 0.25 is associated with significantly reduced all-cause mortality.
May support higher Kt/V targets in CAPD; leaves open survival benefit in randomized trials.
BACKGROUND: The role of small solute clearance on mortalities in patients with CAPD has been controversial. We therefore conducted a study with 3 years' follow up in adult patients who participated in the CAPD-first policy. METHODS: There were 11,523 patients with end-stage renal disease who participated in the CAPD-first policy between 2008 and 2011. Among them, 1,177 patients were included in the retrospective cohort study. A receiver operating characteristic curve was applied to calibrate the cutoffs of tKt/V, rKt/V and tCrcl. Kaplan-Meier and Cox-regression models with time varying covariates were applied to estimate overall death rate, probability of death and prognosis, respectively. RESULTS: The cutoffs of rKt/V and tKt/V were 0.25 and 1.75, respectively. The Cox regression suggested that the higher these clearance parameters, the lower the risks of death after adjusting for covariables. The risks of death for those above these cutoffs were 57% (HR = 0.43, 95% CI: 0.31, 0.60) and 29% (HR = 0.71, 95% CI: 0.52, 0.98) lower for rKt/V and tKt/V, respectively. Age, serum albumin, hemoglobin, systolic blood pressure, and ultra-filtration volume significantly affected the mortality outcome. CONCLUSIONS: Our study suggested that the cutoffs of 0.25 and 1.75 for rKt/V and tKt/V might be associated with mortality in CAPD patients. A minimum tKt/V of 1.75 should be targeted, but increased dialysis dosage to achieve tKt/V > 2.19 adds no further benefit. Serum albumin, hemoglobin, SBP, and UF volume are also associated with mortality. However, our study may face with selection and other unobserved confounders, so further randomized controlled trials are required to confirm these cutoffs.
No takes yet. Share an insight, caveat, or question.
Vejakama et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: